Log Type Authored on Log Message Log Node Authored by
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter clicked Tue, 11/08/2022 - 13:18 Clicked https://za.progress.im/en/content/expert-view-page-0 Anonymous
Newsletter clicked Tue, 11/08/2022 - 13:18 Clicked https://za.progress.im/en/content/are-antipsychotics-needed-long-term-treatment-schizophrenia Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter subscribed Wed, 10/12/2022 - 13:23 Newsletter subscribed - Progress in Mind Brazil newsletter Anonymous
User created Wed, 10/12/2022 - 13:23 User created Anonymous
Newsletter clicked Tue, 11/08/2022 - 13:18 Clicked https://za.progress.im/en/content/new-earn-cpd-points-online-now Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter subscribed Wed, 10/12/2022 - 13:23 Newsletter subscribed - Progress in Mind Brazil newsletter Anonymous
User created Wed, 10/12/2022 - 13:23 User created Anonymous
Log Type Authored on Log Message Log Node Authored by
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter clicked Tue, 11/08/2022 - 13:18 Clicked https://za.progress.im/en/content/expert-view-page-0 Anonymous
Newsletter clicked Tue, 11/08/2022 - 13:18 Clicked https://za.progress.im/en/content/are-antipsychotics-needed-long-term-treatment-schizophrenia Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter subscribed Wed, 10/12/2022 - 13:23 Newsletter subscribed - Progress in Mind Brazil newsletter Anonymous
User created Wed, 10/12/2022 - 13:23 User created Anonymous
Newsletter clicked Tue, 11/08/2022 - 13:18 Clicked https://za.progress.im/en/content/new-earn-cpd-points-online-now Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter subscribed Wed, 10/12/2022 - 13:23 Newsletter subscribed - Progress in Mind Brazil newsletter Anonymous
User created Wed, 10/12/2022 - 13:23 User created Anonymous